New Key Statistics Module, Z-Score and F-Score
NYSE:RDY Key Ratios
Market Cap $ M | 12,996.78 |
Enterprise Value $ M | 12,260.65 |
P/E(ttm) | 19.52 |
PE Ratio without NRI | 21.27 |
Forward PE Ratio | 22.68 |
Price/Book | 3.87 |
Price/Sales | 3.90 |
Price/Free Cash Flow | 60.43 |
Price/Owner Earnings | 20.88 |
Payout Ratio % | 0.13 |
Revenue (TTM) $ M | 3,367.00 |
EPS (TTM) $ | 4.03 |
Beneish M-Score | -2.3 |
10-y EBITDA Growth Rate % | 8.70 |
5-y EBITDA Growth Rate % | 23.00 |
y-y EBITDA Growth Rate % | 18.60 |
EV-to-EBIT | 13.93 |
EV-to-EBITDA | 11.59 |
PEG | 0.92 |
Shares Outstanding M | 166.54 |
Net Margin (%) | 19.95 |
Operating Margin % | 23.39 |
Pre-tax Margin (%) | 25.75 |
Quick Ratio | 1.92 |
Current Ratio | 2.58 |
ROA % (ttm) | 15.78 |
ROE % (ttm) | 21.79 |
ROIC % (ttm) | 22.52 |
Dividend Yield % | 0.62 |
Altman Z-Score | 8.87 |
RDY Number of Guru Trades
RDY Volume of Guru Trades
Gurus Latest Trades with NYSE:RDY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:RDY is held by these investors
Total 1
Dr Reddy's Laboratories Ltd Insider Transactions
No Available Data
News about NYSE:RDY
Total 0- 1